These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35763348)

  • 41. Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination.
    Cox M; Adetifa JU; Noho-Konteh F; Njie-Jobe J; Sanyang LC; Drammeh A; Plebanski M; Whittle HC; Rowland-Jones SL; Robertson I; Flanagan KL
    Front Immunol; 2020; 11():1083. PubMed ID: 32582177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
    Farrell HE; Bruce K; Stevenson PG
    J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.
    Lilleri D; Kabanova A; Revello MG; Percivalle E; Sarasini A; Genini E; Sallusto F; Lanzavecchia A; Corti D; Gerna G
    PLoS One; 2013; 8(3):e59863. PubMed ID: 23555812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.
    Buxmann H; Hamprecht K; Meyer-Wittkopf M; Friese K
    Dtsch Arztebl Int; 2017 Jan; 114(4):45-52. PubMed ID: 28211317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
    Weber B; Braun W; Cinatl J; Doerr HW
    Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.
    Furione M; Rognoni V; Sarasini A; Zavattoni M; Lilleri D; Gerna G; Revello MG
    J Med Virol; 2013 Nov; 85(11):1960-7. PubMed ID: 23893782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.
    Britt W
    Med Microbiol Immunol; 2015 Jun; 204(3):263-71. PubMed ID: 25764180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
    Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
    Vanarsdall AL; Chin AL; Liu J; Jardetzky TS; Mudd JO; Orloff SL; Streblow D; Mussi-Pinhata MM; Yamamoto AY; Duarte G; Britt WJ; Johnson DC
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3728-3733. PubMed ID: 30733288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.
    Kirchmeier M; Fluckiger AC; Soare C; Bozic J; Ontsouka B; Ahmed T; Diress A; Pereira L; Schödel F; Plotkin S; Dalba C; Klatzmann D; Anderson DE
    Clin Vaccine Immunol; 2014 Feb; 21(2):174-80. PubMed ID: 24334684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
    Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
    J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.
    Pötzsch S; Spindler N; Wiegers AK; Fisch T; Rücker P; Sticht H; Grieb N; Baroti T; Weisel F; Stamminger T; Martin-Parras L; Mach M; Winkler TH
    PLoS Pathog; 2011 Aug; 7(8):e1002172. PubMed ID: 21852946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.
    Lilleri D; Gerna G
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28008685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decidual-tissue-resident memory T cells protect against nonprimary human cytomegalovirus infection at the maternal-fetal interface.
    Alfi O; Cohen M; Bar-On S; Hashimshony T; Levitt L; Raz Y; Blecher Y; Chaudhry MZ; Cicin-Sain L; Ben-El R; Oiknine-Djian E; Lahav T; Vorontsov O; Cohen A; Zakay-Rones Z; Daniel L; Berger M; Mandel-Gutfreund Y; Panet A; Wolf DG
    Cell Rep; 2024 Feb; 43(2):113698. PubMed ID: 38265934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
    Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection.
    Boppana SB; Britt WJ
    J Infect Dis; 1995 May; 171(5):1115-21. PubMed ID: 7751685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.